Kossel Medical
Kossel Medical is a Suzhou-based Chinese medical device platform company developing and manufacturing vascular interventional devices including balloons, stents, vena cava filters, and electrophysiology catheters, serving public hospitals across peripheral, coronary, electrophysiology, and neurointerventional departments domestically and in 20+ countries internationally.
- Company typePrivate
- Founded2013
- HeadquartersSuzhou, China
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Kossel Medical does
Kossel Medical (科塞尔医疗科技（苏州）股份有限公司) is a Suzhou-based medical device platform company founded in November 2013, specializing in the R&D, manufacturing, and commercialization of vascular interventional devices. The company operates a "one core, three wings" platform architecture: the parent company focuses on peripheral interventional "one-stop" treatment solutions including the Octoparms retrievable vena cava filter, Tanghulu (糖葫芦) constrained scoring balloon, Falspeed/Falexpand peripheral balloons, K-VisionMax IVUS imaging system, and K-Rhino thrombus aspiration catheters. Subsidiaries address adjacent segments: Mixin Medical (米新医疗) handles coronary intervention products including the MiStent absorbable polymer sirolimus-eluting stent and Selethru/Selepass PTCA balloons; Haiyu Xingchen (海宇新辰) focuses on cardiac electrophysiology devices including Cathios RF ablation catheters, Cathcare/Cathfree mapping catheters, and the Cathlink left bundle branch pacing sheath; Haiwang Medical (海望医疗) develops medical polymer raw materials and offers OEM/CDMO services. The 2026 acquisitions of Baiquantong Medical (active vascular devices) and Xinzhi Medical (coronary drug balloons) extended the platform further.
The company generates revenue primarily through hardware sales of Class III medical devices to hospitals via direct sales teams and distribution partnerships, with pricing determined through government centralized procurement (集中带量采购) tenders at provincial and inter-provincial alliance levels. Distribution reach includes 2,000+ domestic hospitals through direct sales plus a strategic partnership with Jianfa Zhixin (建发致新) covering 3,300+ medical institutions. International sales are conducted in 20+ countries via regional distributors, with regulatory clearances in major markets including US FDA, EU MDR, Japan PMDA, Korea KFDA, India CDSCO, Brazil ANVISA, and Singapore HSA. The company has held 80+ medical device registrations and accumulated over 350 million RMB in R&D investment across 100+ domestic patents and approximately 100 PCT international patents.
Kossel has pursued an aggressive expansion strategy combining organic R&D with inorganic growth, most notably the 2021 acquisition of Ireland-based Micell Technologies (providing supercritical fluid drug coating technology and global clinical data) and the 2026 acquisitions of Baiquantong and Xinzhi Medical. Strategic partnerships established in 2026 with Medtronic (for Seledora coronary plaque balloon commercialization in China) and China Resources Medical Devices (for distribution) reflect commercial scaling efforts. The company completed three venture financing rounds from 2022-2025 totaling approximately 300+ million RMB, is recognized as a National Specialized "Little Giant" (专精特新小巨人) enterprise, and has been designated for the Jiangsu Provincial science and technology enterprise listing cultivation plan, indicating pre-IPO status. Headcount has grown to 600+ employees across the parent and five subsidiaries.
Kossel Medical firmographics
Firmographics- Name
- Kossel Medical
- Legal name
- 科塞尔医疗科技（苏州）股份有限公司
- Website
- https://kosselmed.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Kossel Medical is a Suzhou-based Chinese medical device platform company developing and manufacturing vascular interventional devices including balloons, stents, vena cava filters, and electrophysiology catheters, serving public hospitals across peripheral, coronary, electrophysiology, and neurointerventional departments domestically and in 20+ countries internationally.
- Ownership category
- akta.pro rank
Kossel Medical industry classification
Industry- Product category
- Vascular Interventional Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)
- akta.pro secondary industries
- Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG), Medical & Food-Contact Specialty Compounds (IMANABAK)
Keywords
Where Kossel Medical is headquartered
LocationHeadquarters
- HQ city
- Suzhou
- HQ country
- China
- HQ region
- Asia
Offices5 records
Markets served
Kossel Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Vascular Interventional Device Sales: One-time device sales of balloons, stents, filters, and electrophysiology catheters to hospitals through direct sales and distribution channels. Revenue generated from product sales to over 2000 domestic hospitals and international markets in 20+ countries.
- OEM/CDMO Services: Custom manufacturing services for implantable metal stents, interventional balloons, and electrophysiology catheters for other medical device companies. Haiwin Medical provides CDMO solutions for vascular interventional devices.
- Medical Polymer Materials Supply: Haiwang Medical supplies high-performance polymer tubes and catheter components to medical device manufacturers, supporting domestic supply chain for core raw materials.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Multi-year contract | Government centralized procurement model through provincial and national alliance tendering |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
Kossel Medical product offering
Product offeringCore offering
Kossel Medical is a platform-based medical device manufacturer specializing in vascular interventional devices across four clinical domains: peripheral intervention (vena cava filters, peripheral balloons, IVUS imaging, thrombus aspiration), coronary intervention (PTCA balloons, drug-eluting stents, guidewires, pressure pumps), cardiac electrophysiology (RF ablation catheters, mapping catheters, introducer sheaths), and neuro intervention (intracranial balloons). The company also provides OEM/CDMO contract manufacturing services for other medical device firms and supplies high-performance medical polymer raw materials through its Haiwang Medical subsidiary.
Product overview
科塞尔医疗是泛血管介入器械领域平台型企业，构建"一核三翼"业务布局：母公司科塞尔构建外周介入"一站式"治疗体系（覆盖Octoparms®腔静脉滤器、Falexpand®/Falspeed®/Sugacoated®球囊扩张导管、K-VisionMax™外周IVUS系统、K-Rhino犀牛血栓抽吸导管等产品）；子公司米新医疗聚焦冠脉介入产品研发及境外技术转化（覆盖Selepass®/Selebrek®/Seleminent®球囊扩张导管、MiStent®药物支架、Selepump®压力泵、Selestem®止血器、Seledora®棘突球囊等产品）；子公司海宇新辰深耕心脏电生理领域（覆盖Cathios®/Cathios Cold Front®射频消融导管、Cathcare®/Cathfree®/Cathvenus®标测导管、Caththrough®房间隔穿刺套件、Bridflex®/Birdflex® Plus导引鞘组、Cathlink™电极导线导引鞘组等产品）；子公司海望医疗专攻医用高分子原材料及CDMO定制服务。同时覆盖神经介入产品Yelloach®颅内球囊。公司拥有覆盖诊断、治疗、辅助支持全流程的产品矩阵，产品线包括球囊扩张导管、支架系统、腔静脉滤器、射频消融导管、标测导管、导引鞘组、止血器、压力泵等介入类器械，并提供原材料及定制加工服务。
Differentiator
Problem solved
Functional benefit
Brands
- Octoparms: Umbrella-shaped long-acting vena cava filter - the first domestic umbrella-shaped filter approved in China, with 90-day retrieval window.
- Tanghulu / 糖葫芦
- Selethru
- Selepass
- Selebrek
- Seleminent
- Selepump
- MiStent
- Seledora
- Cathios
- Cathfree
- Cathcare
- Cathrough
- Cathlink / K鞘
- Birdflex
- Cathvenus
- Yelloach
- K-VisionMax / 镜豹
- K-Rhino 犀牛
- Falexpand
- Falspeed
- Sabelly
Products and services
- Octoparms® Vena Cava Filter China's first umbrella-shaped long-acting retrievable vena cava filter with self-centering four-pair balanced arm structure, 90-day retrieval window, and four-point support legs designed to prevent pulmonary embolism. Used by vascular surgery departments for VTE prevention in patients at risk of pulmonary embolism.
- Selepass® PTCA Balloon Dilation Catheter PTCA balloon dilation catheter for dilating stenotic lesions in coronary arteries or bypass grafts via percutaneous transluminal coronary angioplasty (PTCA), improving myocardial blood flow. Used by interventional cardiology departments.
- Selebrek® CTO Coronary Balloon Dilation Catheter Coronary balloon dilation catheter for chronic total occlusion (CTO) lesions, used to dilate stenotic segments in coronary arteries or bypass grafts to improve myocardial perfusion during PCI procedures.
- Seleminent® Coronary Balloon Dilation Catheter PTCA balloon dilation catheter for dilating stenotic lesions in coronary arteries or bypass grafts via percutaneous transluminal coronary angioplasty, improving myocardial blood flow. Used in PCI procedures.
- Seleminent® NC Non-Compliant Coronary Balloon Dilation Catheter Non-compliant PTCA balloon dilation catheter for dilating stenotic lesions in the main trunk or side branches of coronary arteries to improve myocardial blood supply, and for post-stent implantation balloon dilation.
- MiStent® Absorbable Polymer-Coated Sirolimus-Eluting Coronary Stent System Drug-eluting coronary stent based on a 64μm ultra-thin cobalt-chromium alloy stent platform with absorbable polymer coating for 9-month sustained sirolimus release. Polymer absorbs within 45-60 days. Achieves faster endothelialization with demonstrated 0% definite/probable stent thrombosis at 5-year follow-up and 2.7% CD-TLR rate.
- MiSatin® Hydrophilic-Coated Guidewire Hydrophilic-coated guidewire for introducing other devices into blood vessels and establishing percutaneous access pathways. Applicable to coronary and peripheral blood vessels. Used in interventional procedures requiring guidewire access.
- Selepump® Disposable Sterile Pressure Pump Disposable sterile pressure pump used during PTCA procedures to inflate balloon dilation catheters or stent-supporting balloons on balloons. Equipped with precision pressure gauge and safety locking structure for stable pressurization and safe depressurization. PCI auxiliary device for interventional cardiology procedures.
- Selestem® Disposable Radial Artery Hemostat Disposable radial artery hemostasis device used to compress and stop bleeding at the puncture site after radial artery interventional procedures. Used for post-PCI access site management.
- Seledora® Coronary Scoring Balloon Dilation Catheter Coronary scoring balloon dilation catheter for pre-dilation treatment of stenotic coronary lesions before stent implantation or balloon use during PCI procedures in adult patients. Features 0.0165-inch outer diameter and three triangular scoring ridges at 0.42mm height for lesion preparation.
- Cathios® Cardiac Radiofrequency Ablation Catheter Cardiac RF ablation catheter for treatment of tachyarrhythmia, also usable for intracardiac electrophysiological signal mapping, recording, and pacing. Features 1:1 torque response and 16-strand steel wire braided tube body with adjustable head bend for mapping all cardiac sites. Used in electrophysiology departments.
- Cathcare® Fixed-Curve Mapping Catheter Fixed-curve mapping catheter for mapping, recording, and pacing in cardiac electrophysiology diagnosis. Available in various curve types, tube diameters, and lengths with 1:1 torque response for precise tip placement.
- Cathfree® Adjustable-Curve Mapping Catheter Disposable adjustable-curve mapping catheter for intracardiac electrophysiological mapping, recording, and pacing. Used in electrophysiology studies.
- Caththrough® Atrial Septal Puncture Kit Atrial septal puncture kit used for transseptal puncture to guide various interventional devices through femoral vein access into the cardiac chambers. Used in electrophysiology procedures requiring left heart access.
- Bridflex® Adjustable-Curve Introducer Sheath Set Adjustable introducer sheath set used in adult cardiac electrophysiology interventional procedures. Used with electrophysiology recording systems to collect and record intracardiac electrophysiological signals and perform cardiac electrical stimulation.
- Cathlink™ Electrode Lead Introducer Sheath (K鞘) China's first introducer sheath specifically designed for left bundle branch pacing electrode lead delivery, and currently the only sheath in the market usable for atrial pacing electrode delivery. Features hardness gradient design and dual-bend distal structure for surgical safety. Used in physiological pacing procedures.
- Birdflex® Plus Adjustable Introducer Sheath Bidirectional adjustable introducer sheath providing excellent platform support for electrophysiology catheters reaching target cardiac chamber anatomical sites, improving operability, stability, and tissue apposition.
- Cathvenus® Disposable Adjustable Circular Mapping Catheter Disposable adjustable circular mapping catheter for intracardiac electrophysiological mapping, recording, and pacing. Used in atrial fibrillation and other arrhythmia mapping procedures.
- Cathios Cold Front® Disposable Saline-Enhanced RF Ablation Catheter Disposable saline-irrigated RF ablation catheter used with RF ablation systems for treatment of tachyarrhythmia. Used in electrophysiology ablation procedures.
- Yelloach® Intracranial Balloon Dilation Catheter Intracranial balloon dilation catheter for interventional treatment of symptomatic intracranial atherosclerotic stenosis in non-acute phase patients. Restores blood flow and improves perfusion in intracranial arteries via balloon angioplasty. Used in neurointerventional procedures.
- Falexpand® Peripheral High-Pressure Balloon Dilation Catheter Peripheral high-pressure balloon dilation catheter for percutaneous transluminal angioplasty (PTA) procedures in the peripheral vascular system. Used for dilating resistant stenotic lesions in peripheral arteries.
- Falspeed® Peripheral Vascular Balloon Dilation Catheter Peripheral vascular balloon dilation catheter for percutaneous transluminal angioplasty (PTA) of peripheral vascular system including iliac, femoral, popliteal, infrapopliteal, and renal arteries. Also used for treating occlusive lesions in native or artificial AV fistulas for hemodialysis access.
- Sugacoated® (Tanghulu) Peripheral Constrained Scoring Balloon Dilation Catheter Innovative peripheral vascular constrained scoring balloon combining overall constraint and local scoring mechanisms. Provides optimal vessel preparation solutions with expansion force 12x greater than ordinary balloons, effectively reducing rescue stenting requirements. Used for peripheral vessel preparation before drug-coated balloon or stent procedures.
- Sabelly® Non-Compliant Peripheral Balloon Dilation Catheter Non-compliant peripheral balloon dilation catheter for high-pressure peripheral vessel preparation and post-dilation procedures in peripheral intervention.
- Swanec® Vena Cava Filter Retriever Dual-sheath system retriever used for retrieval of implanted vena cava filters. Companion device to Octoparms® vena cava filter enabling filter removal at end of therapeutic period.
- Giranel® Introducer Sheath Set Introducer sheath set for peripheral interventional procedures, used to establish vascular access for introducing interventional devices.
- K-VisionMax™ (镜豹) Peripheral IVUS System Intravascular ultrasound (IVUS) diagnostic imaging system for peripheral vascular intervention procedures. Provides precise intravascular ultrasound imaging for accurate diagnosis and treatment guidance.
- K-Rhino® (犀牛) 14F Large-Bore Thrombus Aspiration Catheter 14F ultra-large bore peripheral thrombus aspiration catheter with thrombus separation technology, four-layer tube body structure, and atraumatic curved-tip design for circumferential aspiration. Used for peripheral thrombectomy in large vessel occlusions.
- Haiwang Medical High-Performance Polymer Materials High-performance polymer tubing and catheter components manufactured by Haiwang Medical subsidiary for interventional medical device OEMs. Addresses "bottleneck" technology in medical core raw materials and provides various tubing and catheter system solutions for medical device manufacturers.
- OEM/CDMO Contract Manufacturing Services Custom contract development and manufacturing services for implantable metal stents, interventional balloons, and electrophysiology catheter products. Provided to other medical device companies through Haiwang Medical (Haiwin) brand under OEM/CDMO arrangements.
Quantifiable outcome
- Octoparms® filter achieved 100% implantation success rate and 100% retrieval success rate in clinical trials with zero PE recurrence
- +3 more outcomes
Companies that use Kossel Medical
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Kossel Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Kossel Medical partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, strategic and minor.
- Medtronic (美敦力)coreStrategic partnership for commercialization of Seledora® coronary棘突球囊扩张导管 in China. Medtronic provides nationwide marketing network, clinical academic promotion system, and industry resources. Kossel provides innovative domestic products with clinical value. Partnership aims to accelerate market access and clinical adoption of the product.
- Jianfa Zhixin (建发致新)coreStrategic distribution partnership covering nationwide vascular intervention product promotion. Jianfa Zhixin operates national distribution network serving 3300+ medical institutions with SPD services. Partnership leverages Kossel's innovative products and Jianfa's channel coverage for rapid market penetration.
- Wenzhou Medical University First Affiliated Hospital (温州医科大学附属第一医院)coreTrilateral cooperation with hospital and Vascular Magic Square incubator for development of Cathlink® electrode lead introducer sheath. Hospital provides clinical innovation concepts and术式 development; Kossel responsible for product development, registration, and commercialization. Partnership enables医工结合 clinical-driven innovation.
- Vascular Magic Square (血管魔方)coreInnovation incubation platform specializing in peripheral vascular and cardiac pacing fields. Serves as technology bridge between clinical needs and product development, assisting with patent filing and early-stage technical validation for new devices.
- China Resources Medical Devices (华润医疗器械)strategicStrategic cooperation agreement for channel collaboration in medical device distribution, leveraging China Resources' established healthcare distribution network.
- Jiangsu Industrial Technology Research Institute (江苏省产业技术研究院)strategicJoint innovation center establishment for collaborative research and development in medical device technology, leveraging institutional resources and academic capabilities.
- Micell Technologies (Ireland)coreAcquired Irish company specializing in supercritical fluid drug coating technology and coronary intervention devices. Acquisition provided access to thousands of global clinical trial data and specialized coating technology, enabling development of ultra-thin drug-eluting stents like MiStent®.
- Suzhou Innovex Medical (苏州茵络医疗)minorStrategic cooperation agreement signed for deep collaboration between peer medical device companies, exploring potential synergies in vascular intervention field.
Scale indicators10 records
Recent moves13 records
Expansion highlights6 records
Kossel Medical competitors and assessment
Company assessmentDirect peers
- Lepu Medical: Lepu Medical is one of China's largest cardiovascular device companies, with direct overlap in drug-eluting stents, balloon catheters, and interventional cardiology devices. Like Kossel, Lepu pursues a platform strategy across cardiovascular subsegments, making it the most direct domestic comparable.
- MicroPort Scientific: MicroPort is a major Chinese medtech group with overlapping coronary intervention, structural heart, and endovascular product lines. Its vascular intervention subsidiaries (MicroPort CardioFlow, Endovastec) compete directly with Kossel's peripheral, coronary, and aortic franchises.
- Acotec Scientific: Acotec Scientific is a Chinese vascular intervention specialist focused on peripheral vascular devices and drug-coated balloons, directly competing with Kossel's peripheral franchise. Listed on HKEX with a comparable product portfolio targeting peripheral vascular disease.
- Lifetech Scientific: Lifetech Scientific is a Chinese cardiovascular implant company specializing in structural heart (LAA occluders, ASD occluders) and peripheral vascular devices. Direct overlap with Kossel's peripheral intervention portfolio and similar international expansion strategy.
- Venmedtech (Jonton Medical): Venmedtech (惠泰医疗) is a Chinese electrophysiology and vascular intervention specialist directly competing with Kossel's Haiyu Xingchen EP subsidiary. Its EP ablation catheters and mapping catheters overlap with Kossel's Cathios and Cathcare product lines.
- Sino Medical Sciences: Sino Medical Sciences (赛诺医疗) is a Chinese developer of drug-eluting stents and interventional cardiology devices, directly competing with Kossel's Mixin Medical coronary subsidiary. Overlap includes drug-coated stents and coronary balloon dilation catheters.
Broad incumbents
- Medtronic: Medtronic is the global leader in coronary stents, EP ablation, and vascular intervention. As Kossel's January 2026 strategic partner for Seledora, Medtronic is simultaneously a major competitive incumbent across Kossel's broader coronary and EP portfolio and the partner for one specific product.
- Abbott Vascular: Abbott is a global incumbent in drug-eluting stents (Xience), EP (Abbott EP), and peripheral vascular intervention. Abbott's broad portfolio and clinical evidence base position it as a primary competitive benchmark in Kossel's target segments.
- Boston Scientific: Boston Scientific is a global leader in EP (acquired Baylis, Blazer), peripheral intervention (Eluvia drug-coated stent), and IVUS. Boston Scientific's overlapping coronary, peripheral, and EP portfolios represent the clinical and commercial standard Kossel's products are benchmarked against.
- Terumo: Terumo is a Japanese global medical device leader in interventional systems (PTCA balloons, stents, access devices), with strong Asia-Pacific distribution overlap. Terumo's Asian manufacturing footprint and coronary intervention portfolio make it a direct comparator for Kossel's coronary and peripheral lines.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Kossel Medical social profiles
Digital presenceKossel Medical compliance and trust
Trust signalCompliance12 records
Kossel Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kossel Medical leadership team
Management profileNumber of profiles
Profiles5 records
Kossel Medical subsidiaries and ownership
Company hierarchySubsidiaries7 records
Kossel Medical funding detail
Funding detailFunding overview
Funding rounds4 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kossel Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kossel Medical
What does Kossel Medical do?
Kossel Medical is a platform-based medical device manufacturer specializing in vascular interventional devices across four clinical domains: peripheral intervention (vena cava filters, peripheral balloons, IVUS imaging, thrombus aspiration), coronary intervention (PTCA balloons, drug-eluting stents, guidewires, pressure pumps), cardiac electrophysiology (RF ablation catheters, mapping catheters, introducer sheaths), and neuro intervention (intracranial balloons). The company also provides OEM/CDMO contract manufacturing services for other medical device firms and supplies high-performance medical polymer raw materials through its Haiwang Medical subsidiary.
Is Kossel Medical a public or private company?
Kossel Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Kossel Medical founded?
Kossel Medical was founded in 2013. It employs 501 to 1,000 people.
Where is Kossel Medical based?
Kossel Medical is headquartered in Suzhou, China, in the Asia region.
How does Kossel Medical make money?
Three revenue lines are on record. Vascular Interventional Device Sales are the primary driver. The others are OEM/CDMO Services and medical Polymer Materials Supply.
Who are Kossel Medical's main competitors?
Direct peers on record are Lepu Medical, MicroPort Scientific, Acotec Scientific, Lifetech Scientific, Venmedtech (Jonton Medical) and Sino Medical Sciences. Broad incumbents are Medtronic, Abbott Vascular, Boston Scientific and Terumo.
Does Kossel Medical have an API?
No public API is recorded for Kossel Medical.
What industry is Kossel Medical in?
Kossel Medical's product category is Vascular Interventional Medical Devices. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation), with a secondary code of HLAIACAG, Cardiology & Vascular Specialty Pharmaceuticals. Its NAICS code is 339112 and its SIC code is 3841.